BXC vs. AGX, BZH, LOMA, TPC, HOV, NX, GLDD, VSEC, LMB, and NOA
Should you be buying BlueLinx stock or one of its competitors? The main competitors of BlueLinx include Argan (AGX), Beazer Homes USA (BZH), Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA), Tutor Perini (TPC), Hovnanian Enterprises (HOV), Quanex Building Products (NX), Great Lakes Dredge & Dock (GLDD), VSE (VSEC), Limbach (LMB), and North American Construction Group (NOA). These companies are all part of the "construction" sector.
Argan (NYSE:AGX) and BlueLinx (NYSE:BXC) are both small-cap construction companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.
79.4% of Argan shares are held by institutional investors. Comparatively, 90.8% of BlueLinx shares are held by institutional investors. 11.9% of Argan shares are held by company insiders. Comparatively, 3.4% of BlueLinx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Argan has a net margin of 5.64% compared to Argan's net margin of 1.57%. Argan's return on equity of 14.11% beat BlueLinx's return on equity.
BlueLinx has higher revenue and earnings than Argan. BlueLinx is trading at a lower price-to-earnings ratio than Argan, indicating that it is currently the more affordable of the two stocks.
Argan has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Comparatively, BlueLinx has a beta of 1.96, meaning that its stock price is 96% more volatile than the S&P 500.
In the previous week, Argan had 1 more articles in the media than BlueLinx. MarketBeat recorded 2 mentions for Argan and 1 mentions for BlueLinx. Argan's average media sentiment score of 1.93 beat BlueLinx's score of 0.67 indicating that BlueLinx is being referred to more favorably in the news media.
Argan received 120 more outperform votes than BlueLinx when rated by MarketBeat users. Likewise, 69.32% of users gave Argan an outperform vote while only 56.07% of users gave BlueLinx an outperform vote.
Argan presently has a consensus price target of $70.00, suggesting a potential upside of 6.16%. BlueLinx has a consensus price target of $130.00, suggesting a potential upside of 29.02%. Given Argan's higher possible upside, analysts plainly believe BlueLinx is more favorable than Argan.
Summary
BlueLinx beats Argan on 9 of the 17 factors compared between the two stocks.
Get BlueLinx News Delivered to You Automatically
Sign up to receive the latest news and ratings for BXC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BXC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BlueLinx Competitors List
Related Companies and Tools
